$2.57
0.020.78%
Last update: Nov 6, 6:37 PM
Editas Medicine Inc
EDITNASDAQ
The average analyst price target for Editas Medicine is $6.76, 163.0% above the current price. Of 14 analysts, 11 rate it Buy, 2 Hold and 1 Sell. Targets range from $3 to $15. The latest change came on Oct 8, 2026, when Wells Fargo upgraded Editas Medicine from Equal-Weight to Overweight and moved its price target from $4 to $6.
Price Target Range — 11 Quarters
Analyst Consensus — 14 Analysts
Rating Trend — Last 9 Months
